Asia-Pacific (APAC) Assisted Reproductive Technology (ART) Procedures Count by Segments and Forecast to 2030

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$3995
Buy Report Download FREE Resources

Published: October 31, 2023 Report Code: GDMEPD1316R09-ST

Select Item

Asia-Pacific (APAC) Assisted Reproductive Technology (ART) Procedures Market Report Overview

The total number of Assisted Reproductive Technology (ART) procedures performed in APAC was 2,264,298 in 2022. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat sub-fertile or infertile women or men such that pregnancy is more likely achieved.

APAC ART Procedures Market Outlook 2022-2030 (Number of Procedures)

APAC ART Procedures Market Outlook 2022-2030 (Number of Procedures)

Buy the Full Report for More Insights on the APAC ART Procedures Market Forecast
Download a Free Sample Report

The APAC ART procedures market research report provides data related to the volumes of ART procedures performed in the country across each segment from 2015 to 2030.

Market Size (Number of Procedures) 2,264,298
Historic Period 2015-2022
Forecast Period 2023-2030
Key Segments •       Intrauterine Insemination (IUI) Cycles

•       In Vitro Fertilization (IVF) Cycles
Key Countries •       Australia

•       China

•       India

•       Japan

•       South Korea
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

APAC ART Procedures Market Segments

The key segments in the APAC ART procedures market are Intrauterine Insemination (IUI) Cycles and In Vitro Fertilization (IVF) Cycles. In 2022, the In Vitro Fertilization (IVF) Cycles segment dominated the APAC ART procedures market share with the highest number of procedures performed.

In Vitro Fertilization (IVF) is one method of ART procedures that increases the probability of achieving pregnancy due to female or male infertility. This includes fresh IVF cycles and frozen IVF cycles. The segment is further expected to retain its market dominance during the projected period.

APAC ART Procedures Market Analysis by Segments, 2022 (%)

APAC ART Procedures Market Analysis by Segments, 2022 (%)

Buy the Full Report for More Segment-Wise Insights in the APAC ART Procedures Market,
Download a Free Sample Report

APAC ART Procedures Market Segmentation by Countries

The key countries in the APAC ART procedures market are Australia, China, India, Japan, and South Korea. In 2022, China dominated the APAC ART procedures market growth and will continue to dominate the market share during the projected period.

APAC ART Procedures Market Analysis by Country, 2022 (%)

APAC ART Procedures Market Analysis by Country, 2022 (%)

Buy the Full Report for More Country-Wise Insights in the APAC ART Procedures Market,
Download a Free Sample Report

Segments Covered in this Report

APAC ART Procedures Market Segment Outlook (Number of Procedures, 2015-2030)

  • Intrauterine Insemination (IUI) Cycles
  • In Vitro Fertilization (IVF) Cycles

APAC ART Procedures Market Country Outlook (Number of Procedures, 2015-2030)

  • Australia
  • China
  • India
  • Japan
  • South Korea

Scope

Asia-Pacific Assisted Reproductive Technology (ART) Procedures is segmented as follows –

• Intrauterine Insemination (IUI) Cycles

• In Vitro Fertilization (IVF) Cycles

Reasons to Buy

APAC Assisted Reproductive Technology (ART) Procedures report helps you to develop –

  • Business strategies by identifying the key segments poised for strong growth in the future.

  • Market-entry and market expansion strategies.

  • Develop investment strategies by identifying the key segments expected to register strong growth in the future.

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables

    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 What Is This Report About?

    • 2.2 Assisted Reproductive Technology (ART) Procedures, Segmentation

    • 2.3 Definitions of Procedures Covered in the Report

  • 3 Assisted Reproductive Technology (ART) Procedures, Asia-Pacific

    • 3.1 Assisted Reproductive Technology (ART) Procedures, Asia-Pacific, 2015-2030

    • 3.2 Assisted Reproductive Technology (ART) Procedures, Asia-Pacific, 2015-2030

  • 4 Assisted Reproductive Technology (ART) Procedures, Australia

    • 4.1 Assisted Reproductive Technology (ART) Procedures, Australia, 2015-2030

      • 4.1.1 In Vitro Fertilization (IVF) Cycles, Australia, 2015-2030

  • 5 Assisted Reproductive Technology (ART) Procedures, China

    • 5.1 Assisted Reproductive Technology (ART) Procedures, China, 2015-2030

      • 5.1.1 In Vitro Fertilization (IVF) Cycles, China, 2015-2030

  • 6 Assisted Reproductive Technology (ART) Procedures, India

    • 6.1 Assisted Reproductive Technology (ART) Procedures, India, 2015-2030

      • 6.1.1 In Vitro Fertilization (IVF) Cycles, India, 2015-2030

  • 7 Assisted Reproductive Technology (ART) Procedures, Japan

    • 7.1 Assisted Reproductive Technology (ART) Procedures, Japan, 2015-2030

      • 7.1.1 In Vitro Fertilization (IVF) Cycles, Japan, 2015-2030

  • 8 Assisted Reproductive Technology (ART) Procedures, South Korea

    • 8.1 Assisted Reproductive Technology (ART) Procedures, South Korea, 2015-2030

      • 8.1.1 In Vitro Fertilization (IVF) Cycles, South Korea, 2015-2030

  • 9 Research Methodology

    • 9.1 Coverage

    • 9.2 Secondary Research

    • 9.3 Primary Research

    • 9.4 Market Modeling and Forecasting

    • 9.5 Company Share Analysis

    • 9.6 Distribution Share Analysis

    • 9.7 Benchmarking

    • 9.8 GlobalData Consulting

  • 10 Appendix

  • 11 About GlobalData

  • 12 Contact Us

Table

List of Tables_x000D_

Table 1: Assisted Reproductive Technology (ART) Procedures, Asia-Pacific, 2015-2030 6_x000D_

Table 2: Assisted Reproductive Technology (ART) Procedures, Asia-Pacific, 2015-2022 8_x000D_

Table 3: Assisted Reproductive Technology (ART) Procedures, Asia-Pacific, 2023-2030 10_x000D_

Table 4: Assisted Reproductive Technology (ART) Procedures, Australia, 2015-2022 12_x000D_

Table 5: Assisted Reproductive Technology (ART) Procedures, Australia, 2023-2030 14_x000D_

Table 6: In Vitro Fertilization (IVF) Cycles, Australia, 2015-2022 16_x000D_

Table 7: In Vitro Fertilization (IVF) Cycles, Australia, 2023-2030 18_x000D_

Table 8: Assisted Reproductive Technology (ART) Procedures, China, 2015-2022 20_x000D_

Table 9: Assisted Reproductive Technology (ART) Procedures, China, 2023-2030 22_x000D_

Table 10: In Vitro Fertilization (IVF) Cycles, China, 2015-2022 24_x000D_

Table 11: In Vitro Fertilization (IVF) Cycles, China, 2023-2030 26_x000D_

Table 12: Assisted Reproductive Technology (ART) Procedures, India, 2015-2022 28_x000D_

Table 13: Assisted Reproductive Technology (ART) Procedures, India, 2023-2030 30_x000D_

Table 14: In Vitro Fertilization (IVF) Cycles, India, 2015-2022 32_x000D_

Table 15: In Vitro Fertilization (IVF) Cycles, India, 2023-2030 34_x000D_

Table 16: Assisted Reproductive Technology (ART) Procedures, Japan, 2015-2022 36_x000D_

Table 17: Assisted Reproductive Technology (ART) Procedures, Japan, 2023-2030 38_x000D_

Table 18: In Vitro Fertilization (IVF) Cycles, Japan, 2015-2022 40_x000D_

Table 19: In Vitro Fertilization (IVF) Cycles, Japan, 2023-2030 42_x000D_

Table 20: Assisted Reproductive Technology (ART) Procedures, South Korea, 2015-2022 44_x000D_

Table 21: Assisted Reproductive Technology (ART) Procedures, South Korea, 2023-2030 46_x000D_

Table 22: In Vitro Fertilization (IVF) Cycles, South Korea, 2015-2022 48_x000D_

Table 23: In Vitro Fertilization (IVF) Cycles, South Korea, 2023-2030 50

Figures

List of Figures_x000D_

Figure 1: Assisted Reproductive Technology (ART) Procedures, Asia-Pacific, 2015-2030 5_x000D_

Figure 2: Assisted Reproductive Technology (ART) Procedures, Asia-Pacific, 2015-2022 7_x000D_

Figure 3: Assisted Reproductive Technology (ART) Procedures, Asia-Pacific, 2023-2030 9_x000D_

Figure 4: Assisted Reproductive Technology (ART) Procedures, Australia, 2015-2022 11_x000D_

Figure 5: Assisted Reproductive Technology (ART) Procedures, Australia, 2023-2030 13_x000D_

Figure 6: In Vitro Fertilization (IVF) Cycles, Australia, 2015-2022 15_x000D_

Figure 7: In Vitro Fertilization (IVF) Cycles, Australia, 2023-2030 17_x000D_

Figure 8: Assisted Reproductive Technology (ART) Procedures, China, 2015-2022 19_x000D_

Figure 9: Assisted Reproductive Technology (ART) Procedures, China, 2023-2030 21_x000D_

Figure 10: In Vitro Fertilization (IVF) Cycles, China, 2015-2022 23_x000D_

Figure 11: In Vitro Fertilization (IVF) Cycles, China, 2023-2030 25_x000D_

Figure 12: Assisted Reproductive Technology (ART) Procedures, India, 2015-2022 27_x000D_

Figure 13: Assisted Reproductive Technology (ART) Procedures, India, 2023-2030 29_x000D_

Figure 14: In Vitro Fertilization (IVF) Cycles, India, 2015-2022 31_x000D_

Figure 15: In Vitro Fertilization (IVF) Cycles, India, 2023-2030 33_x000D_

Figure 16: Assisted Reproductive Technology (ART) Procedures, Japan, 2015-2022 35_x000D_

Figure 17: Assisted Reproductive Technology (ART) Procedures, Japan, 2023-2030 37_x000D_

Figure 18: In Vitro Fertilization (IVF) Cycles, Japan, 2015-2022 39_x000D_

Figure 19: In Vitro Fertilization (IVF) Cycles, Japan, 2023-2030 41_x000D_

Figure 20: Assisted Reproductive Technology (ART) Procedures, South Korea, 2015-2022 43_x000D_

Figure 21: Assisted Reproductive Technology (ART) Procedures, South Korea, 2023-2030 45_x000D_

Figure 22: In Vitro Fertilization (IVF) Cycles, South Korea, 2015-2022 47_x000D_

Figure 23: In Vitro Fertilization (IVF) Cycles, South Korea, 2023-2030 49

Frequently asked questions

Asia-Pacific (APAC) Assisted Reproductive Technology (ART) Procedures Count by Segments and Forecast to 2030 standard reports
Currency USD
$3,995

Can be used by individual purchaser only

Most Popular
$7,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$11,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Asia-Pacific (APAC) Assisted Reproductive Technology (ART) Procedures Count by Segments and Forecast to 2030 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Assisted Reproductive Technology Devices reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Asia-Pacific (APAC) Assisted Reproductive Technology (ART) Procedures Count by Segments and Forecast to 2030 in real time.

  • Access a live Asia-Pacific (APAC) Assisted Reproductive Technology (ART) Procedures Count by Segments and Forecast to 2030 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more